SUMMARY The case notes of 426 women who had been treated for uncomplicated gonorrhoea in 1978-83 inclusive, were studied. The findings for 1978 formed a retrospective basis for a prospective study. The aim was to appraise the value of earlier and fewer follow up tests of cure. The new routine was associated with a more assertive approach to other modalities of control.
Introduction
Since 1977 it has been increasingly emphasised that two sets of smears and cultures are sufficient to establish or exclude a diagnosis of gonorrhoea in women.' 4 The recommendation is based on reciprocal and constant evaluation of clinic and supporting laboratory methods and adequate sampling ofmultiple sites.3 s 6 In some areas special attention has been paid to culture media and the use of immunofluorescence to speed up diagnosis.'
Precision contrasts with recommendations designed to ensure cure. Current British textbooks recommend three or more tests over three months. Thin' recommends urethral and cervical smears and cultures at 1-3, 7, and 14 days after treatment if these cultures are positive rectal specimens are also taken before treatment.
Schofield8 recommended tests over three months; twice within a week oftreatment, then weekly for three successive weeks. Further smears and cultures are recommended after the next two menstrual periods. Patients treated during pregnancy are retested for at least three months. Three consecutive cultures are recommended for patients treated for gonococcal proctitis or pharyngitis. King et al 9 advised three sets of tests, the last one preferably after menstruation.
Two retrospective studies published in 1976 agreed that testing after treatment was neither productive nor cost effective.'0I' Evans'0 emphasised the "paramount importance" of contact tracing, and Chipperfield and Catterall " emphasised the need to exclude reinfection 308 exclude reinfection by undisclosed, untraced, and untreated asymptomatic contacts.
This prospective study aimed to appraise to findings of an updated approach to the follow up of women treated for gonorrhoea. This attempt to declare cure as soon as possible was prompted by: the managerial problems ofgrowing demands by an increasing number ofpatients and a widening variety of sexual infections; the opportunity for improved control of gonorrhoea presented by declining prevalence of the infection in western countries; and the need to test the recommendations of others.'0 O1
Patients and methods
Retrospective study ofpatients treated in 1978 formed the base line of comparison. The prospective part of the study ran from 1 January 1979 to 31 December 1983. The diagnositc methods and their evaluation were the same as those described elsewhere.' 3 S 6 Smear and culture specimens were taken routinely from urethra, endocervix, and rectal wall. The pharynx was sampled selectively for culture alone. Smears were Gram stained and examined immediately. Culture specimens were transferred in Amies' medium twice daily for prompt "plating out" as described by As part of the prospective study, patient education and contact tracing were intensified. Each patient was informed by the doctor of her diagnosis, its personal implications, possible complications, the need for follow up tests, and the epidemiological issues entailed. This was re-emphasised, together with the confidential nature of care, by the health adviser, when she in turn interviewed the patient to collect contact data and to counsel regarding associated social or marital problems. Using contact slips, the patients' co-operative was sought to secure the earliest possible attendance of contacts. Reinterview at the earlier follow up testing times offered an opportunity to thank patients for their co-operation, collect promised contact data, repeat procedures for data collection, or agree the need for the health adviser to seek actively the contact(s) by telephone, letters, or visits or a combination of all these. Similar prompt attention was given to defaulting "culture positive" cases and those defaulting from follow up.From October 1983 patient education was expanded by the issue of fact sheets.
The number ofpatients studied totalled 426, with 60 in the retrospective part (1978) and 366 in the prospective part (1979-83 inclusive).
Results Table I shows that the proportion of patients reattend- Concentrating follow up tests immediately after treatment seems to have advantages. A higher percentage of patients return, cure can be declared within 10 days of treatment, and differentiating treatment failures from reinfection is facilitated. Apart from intensified patient education, we feel that the routine described engendered a shared sense of concern to declare cure as soon as possible. Our findings seem to suggest that time spent on the patient at the initial visit also reduces the need for recall of defaulters. The Jembec culture studies combined with immunofluoresence confirmatory tests, as described by Morton and Jephcott,' suggest that further improvements along the lines described are possible. In particular, treatment failures could be identified earlier, together with their sensitivity to penicillin. This is not only in the best interests of the individual patient but could, both directly and indirectly, prevent dissemination of relatively or completely penicillin resistant strains.
The earlier the first follow up test, with satisfactory results, the more confidently can reinfection be diagnosed. We feel it should be possible, for example, to say to a patient, "did you have intercourse on Saturday or Sunday?" rather than asking her if and when she last had intercourse.
Evans10 had 11 "'positives" in 583 follow up tests in 86' patients. Most were believed to be the result of reinfections. Chipperfield and Catterall" found nine "positives" in 504 follow up tests over several weeks. Like us, these workers wanted to apply more rational routines.
Advancing the first follow up test was welcomed by the health adviser. It helped her to instil in index patients a helpful sense of urgency about the attendance of contacts. This especially applied to uncooperative or dilatory patients, some ofwhom were already known to us as being potential repeaters. This aspect calls for evaluation research. By way of a bonus in recent years we found that the earlier return of patients for the first follow up tests means an earlier start to treatment for those found to have concomitant Chlamydia trachomatis infections.
As regards patient education, Goodrich, who had doubts about the clinical and economic justification of repeated tests of cure, did show that "educational 312 counselling" greatly improved reattendance rates.'4 Our experience leads us to a similar view. The size and epidemiological importance ofthe "repeater" problem has recently been addressed in America'5 16 and the United Kingdom.'7 The last ofthese studies concluded that "repeaters" may comprise a constant proportion of the infected. Our findings confirm this and suggest that the constancy in terms of a figure may be inseparably associated with local morbidity. Much is still to be leamed about the geography of gonorrhoea. Kinghom et all7 described the characteristics of their repeaters. Our modest experience also suggests that potential "repeaters" are an identifiable group calling for special attention in terms of follow up testing.
In conclusion, we recommend the earliest possible follow up of women who have been treated for gonorrhoea: it is managerially worthwhile as it leads to earlier declaration of cure, helps to differentiate treatment failure from reinfections, strengthens contact tracing endeavours, and more rapidly identifies and leads to cure of those with relatively and completely penicillin resistant gonococci. In a non-metropolitan clinic one prompt follow up testing of multiple sites should suffice for most women treated for gonorrhoea.
Such a routine, however, must go hand in hand with an awareness by all clinic staff of the need to identify potential repeaters and to ensure that they have at least two follow up tests.
We thank Dr RS Morton for helpful advice and Mrs A
Harding for her patience with retyping.
gonorrhoea. 
Declaring cure in women with

